2015
DOI: 10.1016/j.ejmech.2015.08.015
|View full text |Cite
|
Sign up to set email alerts
|

Discovery of WQ-3810: Design, synthesis, and evaluation of 7-(3-alkylaminoazetidin-1-yl)fluoro-quinolones as orally active antibacterial agents

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
17
0

Year Published

2017
2017
2022
2022

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 25 publications
(17 citation statements)
references
References 24 publications
0
17
0
Order By: Relevance
“…Of these seven predictions, two predictions were reported as potent activity, three predictions were reported as moderate activity, and two predictions were reported as inactive. Activity values of PubChem CID-122195336 (DNA gyrase; IC 50 = 0.17 µM; Itoh et al, 2015) and PubChem CID-122195337 (DNA gyrase; IC 50 = 0.41 µM; Itoh et al, 2015) were reported as potent activity; binfloxacin (topoisomerase IV subunit A; IC 50 = 10 µM; Gaulton et al, 2017), ecenofloxacin (topoisomerase IV subunit A; IC 50 = 10 µM; Gaulton et al, 2017), and irloxacin (topoisomerase IV subunit A; IC 50 = 10 µM; Gaulton et al, 2017) were reported as moderate activity; and PD 118362 (DNA gyrase; IC 50 = 66.75 µM; Domagala et al, 1988) and PD 111834 (DNA gyrase; IC 50 = 201 µM; Domagala et al, 1986) were reported as inactive.…”
Section: Resultsmentioning
confidence: 99%
“…Of these seven predictions, two predictions were reported as potent activity, three predictions were reported as moderate activity, and two predictions were reported as inactive. Activity values of PubChem CID-122195336 (DNA gyrase; IC 50 = 0.17 µM; Itoh et al, 2015) and PubChem CID-122195337 (DNA gyrase; IC 50 = 0.41 µM; Itoh et al, 2015) were reported as potent activity; binfloxacin (topoisomerase IV subunit A; IC 50 = 10 µM; Gaulton et al, 2017), ecenofloxacin (topoisomerase IV subunit A; IC 50 = 10 µM; Gaulton et al, 2017), and irloxacin (topoisomerase IV subunit A; IC 50 = 10 µM; Gaulton et al, 2017) were reported as moderate activity; and PD 118362 (DNA gyrase; IC 50 = 66.75 µM; Domagala et al, 1988) and PD 111834 (DNA gyrase; IC 50 = 201 µM; Domagala et al, 1986) were reported as inactive.…”
Section: Resultsmentioning
confidence: 99%
“…It was found that introduction of alkyl groups (C0–C4) into 7‐(3‐alkylaminoazetidin‐1‐yl)fluoroquinolones resulted in increasing of lipophilicity and hence oral absorption by enhancing the membrane permeability . This study had demonstrated that WQ‐3810 57 was highly active against quinolone‐resistant pathogens with MIC values between 0.010 and 0.2 μg/mL which was higher than that of levofloxacin against the tested strains of Gram‐negative bacteria with a good pharmacokinetic profile as well as a low potential for side effects …”
Section: Recent Advances Of Quinolone Antibacterial Agentsmentioning
confidence: 93%
“…Highly substituted piperazines can be expected to increase antimicrobial activity probably by enhancing lipophilicity of molecule . Mainly, piperazine nucleus constitutes an active part of fluoroquinolone class antibacterial drugs such as ciprofloxacin, enoxacine, pefloxacine, fleroxacine, ofloxacine, and grepafloxacine . In some of our previous studies, some 1,2,4‐triazole‐ N ‐substituted piperazine conjugates have been obtained as antibacterial and/or antifungal agents .…”
Section: Introductionmentioning
confidence: 99%